Catalyst Wire Dossier Catalyst Wire Dossier

SURFAXIN

lucinactant · Windtree Therapeutics
Drug timelines are a Plus or Pro feature.

4 regulatory and trial events tracked for SURFAXIN, covering 2006-06-08 to 2012-06-13. Get the full timeline:

Most recent: Clinical Trial Update: SURFAXIN® Treatment for Prevention of Bronchopulmonary Dysplasia (BPD) in Very Low Birth Weight (VLBW) Infants. [Phase 2]

See pricing